This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Genetics

Authoring team

Myotonic dystrophy is an autosomal dominant disease with an incidence of 5 per 100000. The gene is located on chromosome 19.

The genetic defect is a trinucleotide expansion within the 3' untranslated region of the mRNA of the myotonin-protein kinase gene, which results in decreased expression of the protein.

Myotonic dystrophy exhibits the phenomenon of genetic anticipation - the disease becomes more severe down the generations of an affected family as a result of repeated expansion of the (CTG/CAG)n trinucleotide repeats, probably during gametogenesis.

The number of repeats in affected individuals is very large, about 200 - 400 copies (1).

Reference:

  • Fu, Y.-H. et al., Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy, Science, 1993, 260, p.235-7

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.